{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459812959
| IUPAC_name = [(3''R'',3''aS'',6''aR'')-2,3,3''a'',4,5,6''a''-Hexahydrofuro[5,4-''b'']furan-3-yl] ''N''-[(2''S'',3''R'')-4-(1,3-benzodioxol-5-ylsulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-[4-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]butan-2-yl]carbamate
| image = Brecanavir structure.svg
| width = 260

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 313682-08-5
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 206031
| PubChem = 5743186
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = E367I8C7FI
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4675192
| smiles = O=S(=O)(c2ccc1OCOc1c2)N(CC(C)C)C[C@@H](O)[C@@H](NC(=O)O[C@@H]3[C@@H]4CCO[C@@H]4OC3)Cc6ccc(OCc5nc(sc5)C)cc6
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JORVRJNILJXMMG-OLNQLETPSA-N

<!--Chemical data-->
| chemical_formula =  
| C=33 | H=41 | N=3 | O=10 | S=2 
| molecular_weight = 703.82
}}

'''Brecanavir''' ([[International Nonproprietary Name|INN]]; codenamed '''GW640385''') is a [[Protease inhibitor (pharmacology)|protease inhibitor]] which has been studied for the treatment of [[HIV]].<ref>{{cite journal |vauthors=Hazen R, Harvey R, Ferris R |title=In vitro antiviral activity of the novel, tyrosyl-based human immunodeficiency virus (HIV) type 1 protease inhibitor brecanavir (GW640385) in combination with other antiretrovirals and against a panel of protease inhibitor-resistant HIV |journal=Antimicrob. Agents Chemother. |volume=51 |issue=9 |pages=3147â€“54 |date=September 2007 |pmid=17620375 |pmc=2043237 |doi=10.1128/AAC.00401-07 |url=|display-authors=etal}}</ref>

On December 2006, its developer, [[GlaxoSmithKline]] discontinued further development because of insurmountable issues regarding formulation.<ref>
{{cite press release
  | title = GlaxoSmithKline discontinues clinical development of investigational protease inhibitor brecanavir (640385)
  | publisher = [[GlaxoSmithKline]]
  | date = 2006-12-18
  | url = http://www.gsk.com/media/pressreleases/2006/2006_12_18_GSK945.htm
  | accessdate = 2008-06-11
  | deadurl = yes
  | archiveurl = https://web.archive.org/web/20081203151032/http://www.gsk.com/media/pressreleases/2006/2006_12_18_GSK945.htm
  | archivedate = 2008-12-03
  | df = 
  }}</ref>

==See also==
* [[Darunavir]]

==References==
{{Reflist}}

{{HIVpharm}}

[[Category:Abandoned drugs]]
[[Category:Alcohols]]
[[Category:Benzodioxoles]]
[[Category:Carbamates]]
[[Category:Furofurans]]
[[Category:HIV protease inhibitors]]
[[Category:Phenol ethers]]
[[Category:Thiazoles]]

{{Antiinfective-agent-stub}}